{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:55:53Z","timestamp":1773507353720,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.diabres.2021.108794","type":"journal-article","created":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T17:52:56Z","timestamp":1617645176000},"page":"108794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Heart failure outcomes and Covid-19"],"prefix":"10.1016","volume":"175","author":[{"given":"Eberhard","family":"Standl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108794_b0005","doi-asserted-by":"crossref","unstructured":"Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. DOI: 10.1056\/NEJMoa2001017.","DOI":"10.1056\/NEJMoa2001017"},{"key":"10.1016\/j.diabres.2021.108794_b0010","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"China medical treatment expert group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.diabres.2021.108794_b0015","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","volume":"382","author":"Rothe","year":"2020","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.diabres.2021.108794_b0020","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1056\/NEJMc2001801","article-title":"Covid-19 in South Korea - challenges of subclinical manifestations","volume":"382","author":"Song","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108794_b0025","doi-asserted-by":"crossref","unstructured":"Gentile S, Strollo F, Ceriello A. COVID-19 infection in Italian People with diabetes: lessons learned for our future (an experience to be used). Diab Res Clin Pract April 4 2020 [Epub ahead of print]. DOI: 10.1016\/j.diabres.2020.108137","DOI":"10.1016\/j.diabres.2020.108137"},{"key":"10.1016\/j.diabres.2021.108794_b0030","first-page":"271","article-title":"The characteristics of 50 hospitalized COVID-19 patients with and without ARDS","volume":"117","author":"Dreher","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.diabres.2021.108794_b0035","doi-asserted-by":"crossref","unstructured":"Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 17 April 2020 [Epub ahead of print]. DOI: 10.1056\/NEJMc2010419","DOI":"10.1056\/NEJMc2010419"},{"issue":"7","key":"10.1016\/j.diabres.2021.108794_b0040","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2337\/dc20-0941","article-title":"Issues of cardiovascular risk management in people with diabetes in the COVID-19 era","volume":"43","author":"Ceriello","year":"2020","journal-title":"Diabetes Care"},{"issue":"20","key":"10.1016\/j.diabres.2021.108794_b0045","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.jacc.2020.09.549","article-title":"Prognostic impact of prior heart failure in patients hospitalized with COVID-19","volume":"76","author":"Alvarez-Garcia","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.diabres.2021.108794_b0050","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/ejhf.1990","article-title":"Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications","volume":"22","author":"Rey","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.diabres.2021.108794_b0055","doi-asserted-by":"crossref","unstructured":"Wargny M, Potier L, Gourdy P et al. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia 2021 Feb 17;1-17. doi: 10.1007\/s00125-020-05351-w. Online ahead of print.","DOI":"10.1007\/s00125-020-05351-w"},{"issue":"15","key":"10.1016\/j.diabres.2021.108794_b0060","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jama.2020.19545","article-title":"Excess deaths from COVID-19 and other causes, March-July 2020","volume":"324","author":"Woolf","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.diabres.2021.108794_b0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2020.24865","article-title":"COVID-19 as the leading cause of death in the United States","volume":"325","author":"Woolf","year":"2021","journal-title":"JAMA"},{"issue":"368","key":"10.1016\/j.diabres.2021.108794_b0070","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"26","author":"Chen","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.diabres.2021.108794_b0075","doi-asserted-by":"crossref","first-page":"16384","DOI":"10.1038\/s41598-020-73136-7","article-title":"Analysis of the clinical characteristics of 77 COVID-19 deaths","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.diabres.2021.108794_b0080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2021.108794_b0085","doi-asserted-by":"crossref","unstructured":"Koh HK, GellerAC, VanderWeele TJ. Deaths From COVID-19. JAMA 2021 Jan 12;325(2):133-134. doi: 10.1001\/jama.2020.25381.","DOI":"10.1001\/jama.2020.25381"},{"issue":"10234","key":"10.1016\/j.diabres.2021.108794_b0090","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2021.108794_b0095","doi-asserted-by":"crossref","unstructured":"Yonas E, Alwi I, Pranata R et al. Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review. Am J Emerg Med. 2020 Jul 9: S0735-6757(20)30602-1. doi: 10.1016\/j.ajem.2020.07.009. Online ahead of print.","DOI":"10.1016\/j.ajem.2020.07.009"},{"key":"10.1016\/j.diabres.2021.108794_b0100","doi-asserted-by":"crossref","unstructured":"Zhang Y, Xiao M, Zhang S et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020 Apr 23;382(17):e38. doi: 10.1056\/NEJMc2007575. Epub 2020 Apr 8","DOI":"10.1056\/NEJMc2007575"},{"key":"10.1016\/j.diabres.2021.108794_b0105","doi-asserted-by":"crossref","unstructured":"Dawson D, Dominic P, Sheth A, Modi M. Prognostic value of cardiac biomarkers in COVID-19 infection: a meta-analysis. Res Sq 2020 Jun 13;rs.3.rs-34729. doi: 10.21203\/rs.3.rs-34729\/v1.","DOI":"10.21203\/rs.3.rs-34729\/v1"},{"issue":"8","key":"10.1016\/j.diabres.2021.108794_b0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40364-020-00217-0","article-title":"A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)","volume":"31","author":"Danwang","year":"2020","journal-title":"Biomark Res"},{"key":"10.1016\/j.diabres.2021.108794_b0115","doi-asserted-by":"crossref","unstructured":"Stefanini GG, Chiarito M, Ferrante G et al on behalf of the Humanitas COVID-19 Task Force. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart 2020;106:1512\u20131518.","DOI":"10.1136\/heartjnl-2020-317322"},{"key":"10.1016\/j.diabres.2021.108794_b0120","doi-asserted-by":"crossref","unstructured":"Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507\u201313.","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"10.1016\/j.diabres.2021.108794_b0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China Lancet"},{"key":"10.1016\/j.diabres.2021.108794_b0130","doi-asserted-by":"crossref","unstructured":"Inciardi RM, Lupi L, Zaccone G et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol doi: 10.1001\/jamacardio.2020.1096, Published online March 27, 2020.","DOI":"10.1001\/jamacardio.2020.1096"},{"key":"10.1016\/j.diabres.2021.108794_b0135","doi-asserted-by":"crossref","unstructured":"Abbasi J. Researchers Investigate What COVID-19 Does to the Heart. JAMA 2021 Feb 10. doi: 10.1001\/jama.2021.0107. Online ahead of print","DOI":"10.1001\/jama.2021.0107"},{"key":"10.1016\/j.diabres.2021.108794_b0140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/CIRCULATIONAHA.120.047971","article-title":"The spectrum of cardiac manifestations in coronavirus disease 2019 (COVID-19) -a systematic echocardiographic study","volume":"142","author":"Szekely","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108794_b0145","doi-asserted-by":"crossref","unstructured":"Shahrbaf MA, Tabary M, Khaheshi I. The right ventricle in COVID-19 patients. Eur Heart J 2021; 42(6) 7Feb: 559-560","DOI":"10.1093\/eurheartj\/ehaa832"},{"key":"10.1016\/j.diabres.2021.108794_b0150","article-title":"Autopsy findings in COVID-19-related deaths: a literature review","author":"Maiese","year":"2020","journal-title":"Forensic Sci Med Pathol"},{"key":"10.1016\/j.diabres.2021.108794_b0155","doi-asserted-by":"crossref","DOI":"10.1111\/his.14134","article-title":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction","author":"Menter","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.diabres.2021.108794_b0160","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2020.8907","article-title":"Postmortem examination of patients with COVID-19","volume":"323","author":"Schaller","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108794_b0165","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/infdis\/jiaa528","article-title":"Circulating endothelial cells as a marker of endothelial injury in severe COVID -19","volume":"222","author":"Guervilly","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diabres.2021.108794_b0170","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)","volume":"5","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.diabres.2021.108794_b0175","first-page":"1","article-title":"Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance","volume":"00","author":"Kotecha","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2021.108794_b0180","doi-asserted-by":"crossref","unstructured":"Tsch\u00f6pe C, Ammirati E, Bozkurt B et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 2020;https:\/\/doi.org\/10.1038\/s41569-020-00435-x.","DOI":"10.1038\/s41569-020-00435-x"},{"issue":"6","key":"10.1016\/j.diabres.2021.108794_b0185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/eurheartj\/ehaa988","article-title":"A patient with rapid worsening dyspnoea during Covid-19 pandemic","volume":"42","author":"Baggiano","year":"2021","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.diabres.2021.108794_b0190","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.2020.17445","article-title":"COVID-19 and heart failure with preserved ejection fraction","volume":"324","author":"Freaney","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108794_b0195","doi-asserted-by":"crossref","unstructured":"ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization. J Am Coll Cardiology 2021, doi: https:\/\/doi.org\/10.1016\/j.jacc.2021.02.017","DOI":"10.1016\/j.jacc.2021.02.017"},{"issue":"281\u2013292","key":"10.1016\/j.diabres.2021.108794_b0200","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.diabres.2021.108794_b0205","doi-asserted-by":"crossref","unstructured":"Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract 29 March 2020 [Epub ahead of print]. DOI: 10.1016\/j.diabres.2020.108132","DOI":"10.1016\/j.diabres.2020.108132"},{"key":"10.1016\/j.diabres.2021.108794_b0210","doi-asserted-by":"crossref","unstructured":"Zhang P, Zhu L, Cai J, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 17 April 2020 [Epub ahead of print]. DOI: 10.1161\/CIRCRESAHA.120.317134","DOI":"10.1161\/CIRCRESAHA.120.317134"},{"key":"10.1016\/j.diabres.2021.108794_b0215","unstructured":"European Medicines Agency. EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic. Accessed 21 January 2021. Available from https:\/\/www.ema.europa.eu\/en\/news\/ema-advisescontinued-use-medicines-hypertension-heartkidney-disease-during-covid-19-pandemic"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721001534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721001534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:16:39Z","timestamp":1759173399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721001534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":43,"alternative-id":["S0168822721001534"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108794","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure outcomes and Covid-19","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108794"}}